Project Details
Description
The stated goal of RHAPSODY is to define a molecular taxonomy of type 2 diabetes mellitus (T2D) that will support patient segmentation, inform clinical trial design, and the establishment of regulatory paths for the adoption of novel strategies for diabetes prevention and treatment.
Popular science description
RHAPSODY plans to characterise those patients who i) progress to T2D diagnosis and ii) those T2D patients who eventually progress onto treatment by insulin.
| Short title | IMI2 RHAPSODY |
|---|---|
| Acronym | IMI2 RHAPSODY |
| Status | Finished |
| Effective start/end date | 2016/04/01 → 2021/09/30 |
Collaborative partners
- Lund University (lead)
UKÄ subject classification
- Medical and Health Sciences